WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) today announced the initial list of presenting companies for the 14th Annual BIO Investor Forum, an international investor forum which explores investment trends and opportunities in life sciences. The event focuses on early and mid-stage private as well as emerging public companies that are poised for growth in 2016. The event will take place October 20-21, 2015, at the Parc 55 in San Francisco, California.
“We have a superb slate of over 100 companies signed up to present at this year’s BIO Investor Forum, and a global group of investors are lining up to hear from them,” said BIO President and CEO Jim Greenwood. “Based on current investor registration, we anticipate that attending investors’ assets under management and available funds will exceed all prior years, representing an excellent opportunity for companies looking for their next round of funding.”
Companies were chosen through a competitive screening process with input from BIO and the event’s advisory committee. The committee is comprised of members from top-tier firms focused on investing and banking in the life sciences industry in addition to executives from emerging and leading biotech and pharmaceutical companies.
The following companies are expected to present at the 14th Annual BIO Investor Forum:
Axikin Pharmaceuticals, Inc.
C3 Jian, Inc.
Cantex Pharmaceuticals, Inc.
Protagonist Therapeutics Inc.
Silver Creek Pharmaceuticals, Inc.
Thrasos Therapeutics Inc.
True North Therapeutics, Inc.
BioScience Holdings, Inc.
Apricus Biosciences, Inc.
Aptose Biosciences Inc.
Atossa Genetics Inc.
Bio-Path Holdings, Inc.
Catalyst Pharmaceuticals, Inc.
Corbus Pharmaceuticals Holdings, Inc.
Critical Outcome Technologies Inc.
DelMar Pharmaceuticals, Inc.
Helix Biopharma Corp.
Mast Therapeutics, Inc.
Matinas BioPharma Holdings, Inc.
Newron Pharmaceuticals SpA
Nuvo Research Inc.
Ocera Therapeutics, Inc.
OncoSec Medical, Inc.
Oxis International, Inc.
Palatin Technologies, Inc.
RepliCel Life Sciences Inc.
RXi Pharmaceuticals Corporation
Synthetic Biologics, Inc.
Tokai Pharmaceuticals, Inc.
Viking Therapeutics, Inc.
Patient Advocacy/Non-Profit Organizations:
In addition, the 14th Annual BIO Investor Forum will again host Discovery Track presentations, which focus on companies incorporated after 2010 that have raised less than $25M to date in seed or Series A financing rounds. Companies in this track are also first-time presenters and use biotechnology or related technologies for research and development of drug products or diagnostics. The following companies are scheduled to present in the Discovery Track:
AhR Pharmaceuticals, Inc.
Avelas Biosciences, Inc.
BioCurity Holdings, Inc.
Capella Therapeutics, Inc.
Embera NeuroTherapeutics, Inc.
Euclises Pharmaceuticals, Inc.
Magnus Life Science
Neovia Oncology Ltd
Susavion Biosciences, Inc.
Synergys Biotherapeutics, Inc.
Valley Fever Solutions
The BIO Investor Forum is the must-attend event for public and private market investors, research analysts, investment bankers, and industry executives focused on investment and business development opportunities in life sciences. BIO One-on-One Partnering™ will also provide an opportunity to arrange meetings between investors; companies; and industry business development, licensing and therapeutic franchise heads.
BIO is pleased to recognize the leadership provided by the BIO Investor Forum Conference sponsors including our Regional Co-Hosts, BIOCOM and the California Life Sciences Association, as well as our Supporting Bank Sponsor, Roth Capital Partners. BIO Double Helix and Helix Sponsors include AbbVie, Amgen, Baxalta, Eli Lilly, Johnson & Johnson Innovation, Merck and Takeda Ventures. Conference sponsors include Aon Risk Solutions, Ash Stevens Inc., Bioscience Advisors, Blaise Group International, the Chubb Group of Insurance Companies, Clinical Network Services (CNS) PTY LTD, Fenwick & West LLP, FreeMind Group, Knobbe Martens, Morrison & Foerster LLP, NDA Group, Sichenzia Ross Friedman Ference LLP, Tiberend Strategic Advisors, Torreya Partners and VWR.
To learn more about the BIO Investor Forum, including registration and program information, please visit here. Registration is complimentary for credentialed members of the media and qualified investors.
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.
Upcoming BIO Events
|September 18, 2015||October 14-16, 2015|
|Alexandria, VA||Rio de Janeiro, Brazil|
|October 14, 2015||October 20-21, 2015|
|Washington, D.C.||San Francisco, Calif.|
|November 2-4, 2015||November 16-18, 2015|
|Munich, Germany||Cary/Raleigh, NC|
|February 8-9, 2016||March 15-16, 2016|
|New York, New York||Tokyo, Japan|
|June 6-9, 2016|
|San Francisco, Calif.|